ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pre-Exposure Prophylaxis Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-14X10235
Home | Market Reports | Health| Reproductive Health
Global Pre Exposure Prophylaxis Market Insights Forecast to 2028
BUY CHAPTERS

Global Pre-Exposure Prophylaxis Market Research Report 2025

Code: QYRE-Auto-14X10235
Report
July 2025
Pages:69
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Gilead Sciences
Teva Pharmaceuticals
Strides Pharma Science
Lupin Ltd

Pre-Exposure Prophylaxis Market Size

The global market for Pre-Exposure Prophylaxis was valued at US$ 255 million in the year 2024 and is projected to reach a revised size of US$ 357 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Pre-Exposure Prophylaxis Market

Pre-Exposure Prophylaxis Market

PrEP, or pre-exposure prophylaxis, is a medicine to prevent HIV. People who are not infected with HIV can take this medicine to decrease the risk of contracting HIV if they get infected with the virus. PrEP is used to stop HIV from spreading throughout one"s body. At present, only two daily oral PrEP medications are FDA-approved. Truvada and Descovy are the drugs approved by the FDA for oral usage. Physicians prescribe PrEP to adults and adolescents who are HIV negative and at a higher risk of getting HIV due to sex or injection use.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pre-Exposure Prophylaxis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pre-Exposure Prophylaxis.
The Pre-Exposure Prophylaxis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pre-Exposure Prophylaxis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pre-Exposure Prophylaxis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pre-Exposure Prophylaxis Market Report

Report Metric Details
Report Name Pre-Exposure Prophylaxis Market
Accounted market size in year US$ 255 million
Forecasted market size in 2031 US$ 357 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Truvada
  • Discovy
Segment by Application
  • Adult
  • Adolescent
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Gilead Sciences, Teva Pharmaceuticals, Strides Pharma Science, Lupin
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pre-Exposure Prophylaxis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pre-Exposure Prophylaxis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Pre-Exposure Prophylaxis Market growing?

Ans: The Pre-Exposure Prophylaxis Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Pre-Exposure Prophylaxis Market size in 2031?

Ans: The Pre-Exposure Prophylaxis Market size in 2031 will be US$ 357 million.

Who are the main players in the Pre-Exposure Prophylaxis Market report?

Ans: The main players in the Pre-Exposure Prophylaxis Market are Gilead Sciences, Teva Pharmaceuticals, Strides Pharma Science, Lupin

What are the Application segmentation covered in the Pre-Exposure Prophylaxis Market report?

Ans: The Applications covered in the Pre-Exposure Prophylaxis Market report are Adult, Adolescent

What are the Type segmentation covered in the Pre-Exposure Prophylaxis Market report?

Ans: The Types covered in the Pre-Exposure Prophylaxis Market report are Truvada, Discovy

Recommended Reports

HIV & Antiretroviral

Diagnostics & Testing

Pharma Services & Kits

1 Pre-Exposure Prophylaxis Market Overview
1.1 Product Definition
1.2 Pre-Exposure Prophylaxis by Type
1.2.1 Global Pre-Exposure Prophylaxis Market Value Comparison by Type (2024 VS 2031)
1.2.2 Truvada
1.2.3 Discovy
1.3 Pre-Exposure Prophylaxis by Application
1.3.1 Global Pre-Exposure Prophylaxis Market Value by Application (2024 VS 2031)
1.3.2 Adult
1.3.3 Adolescent
1.4 Global Pre-Exposure Prophylaxis Market Size Estimates and Forecasts
1.4.1 Global Pre-Exposure Prophylaxis Revenue 2020-2031
1.4.2 Global Pre-Exposure Prophylaxis Sales 2020-2031
1.4.3 Global Pre-Exposure Prophylaxis Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pre-Exposure Prophylaxis Market Competition by Manufacturers
2.1 Global Pre-Exposure Prophylaxis Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pre-Exposure Prophylaxis Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pre-Exposure Prophylaxis Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pre-Exposure Prophylaxis, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pre-Exposure Prophylaxis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pre-Exposure Prophylaxis, Product Type & Application
2.7 Global Key Manufacturers of Pre-Exposure Prophylaxis, Date of Enter into This Industry
2.8 Global Pre-Exposure Prophylaxis Market Competitive Situation and Trends
2.8.1 Global Pre-Exposure Prophylaxis Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pre-Exposure Prophylaxis Players Market Share by Revenue
2.8.3 Global Pre-Exposure Prophylaxis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pre-Exposure Prophylaxis Market Scenario by Region
3.1 Global Pre-Exposure Prophylaxis Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pre-Exposure Prophylaxis Sales by Region: 2020-2031
3.2.1 Global Pre-Exposure Prophylaxis Sales by Region: 2020-2025
3.2.2 Global Pre-Exposure Prophylaxis Sales by Region: 2026-2031
3.3 Global Pre-Exposure Prophylaxis Revenue by Region: 2020-2031
3.3.1 Global Pre-Exposure Prophylaxis Revenue by Region: 2020-2025
3.3.2 Global Pre-Exposure Prophylaxis Revenue by Region: 2026-2031
3.4 North America Pre-Exposure Prophylaxis Market Facts & Figures by Country
3.4.1 North America Pre-Exposure Prophylaxis Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pre-Exposure Prophylaxis Sales by Country (2020-2031)
3.4.3 North America Pre-Exposure Prophylaxis Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pre-Exposure Prophylaxis Market Facts & Figures by Country
3.5.1 Europe Pre-Exposure Prophylaxis Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pre-Exposure Prophylaxis Sales by Country (2020-2031)
3.5.3 Europe Pre-Exposure Prophylaxis Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pre-Exposure Prophylaxis Market Facts & Figures by Region
3.6.1 Asia Pacific Pre-Exposure Prophylaxis Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pre-Exposure Prophylaxis Sales by Region (2020-2031)
3.6.3 Asia Pacific Pre-Exposure Prophylaxis Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pre-Exposure Prophylaxis Market Facts & Figures by Country
3.7.1 Latin America Pre-Exposure Prophylaxis Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pre-Exposure Prophylaxis Sales by Country (2020-2031)
3.7.3 Latin America Pre-Exposure Prophylaxis Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pre-Exposure Prophylaxis Market Facts & Figures by Country
3.8.1 Middle East and Africa Pre-Exposure Prophylaxis Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pre-Exposure Prophylaxis Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pre-Exposure Prophylaxis Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pre-Exposure Prophylaxis Sales by Type (2020-2031)
4.1.1 Global Pre-Exposure Prophylaxis Sales by Type (2020-2025)
4.1.2 Global Pre-Exposure Prophylaxis Sales by Type (2026-2031)
4.1.3 Global Pre-Exposure Prophylaxis Sales Market Share by Type (2020-2031)
4.2 Global Pre-Exposure Prophylaxis Revenue by Type (2020-2031)
4.2.1 Global Pre-Exposure Prophylaxis Revenue by Type (2020-2025)
4.2.2 Global Pre-Exposure Prophylaxis Revenue by Type (2026-2031)
4.2.3 Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2020-2031)
4.3 Global Pre-Exposure Prophylaxis Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pre-Exposure Prophylaxis Sales by Application (2020-2031)
5.1.1 Global Pre-Exposure Prophylaxis Sales by Application (2020-2025)
5.1.2 Global Pre-Exposure Prophylaxis Sales by Application (2026-2031)
5.1.3 Global Pre-Exposure Prophylaxis Sales Market Share by Application (2020-2031)
5.2 Global Pre-Exposure Prophylaxis Revenue by Application (2020-2031)
5.2.1 Global Pre-Exposure Prophylaxis Revenue by Application (2020-2025)
5.2.2 Global Pre-Exposure Prophylaxis Revenue by Application (2026-2031)
5.2.3 Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2020-2031)
5.3 Global Pre-Exposure Prophylaxis Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Gilead Sciences
6.1.1 Gilead Sciences Company Information
6.1.2 Gilead Sciences Description and Business Overview
6.1.3 Gilead Sciences Pre-Exposure Prophylaxis Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Gilead Sciences Pre-Exposure Prophylaxis Product Portfolio
6.1.5 Gilead Sciences Recent Developments/Updates
6.2 Teva Pharmaceuticals
6.2.1 Teva Pharmaceuticals Company Information
6.2.2 Teva Pharmaceuticals Description and Business Overview
6.2.3 Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Pharmaceuticals Pre-Exposure Prophylaxis Product Portfolio
6.2.5 Teva Pharmaceuticals Recent Developments/Updates
6.3 Strides Pharma Science
6.3.1 Strides Pharma Science Company Information
6.3.2 Strides Pharma Science Description and Business Overview
6.3.3 Strides Pharma Science Pre-Exposure Prophylaxis Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Strides Pharma Science Pre-Exposure Prophylaxis Product Portfolio
6.3.5 Strides Pharma Science Recent Developments/Updates
6.4 Lupin
6.4.1 Lupin Company Information
6.4.2 Lupin Description and Business Overview
6.4.3 Lupin Pre-Exposure Prophylaxis Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lupin Pre-Exposure Prophylaxis Product Portfolio
6.4.5 Lupin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pre-Exposure Prophylaxis Industry Chain Analysis
7.2 Pre-Exposure Prophylaxis Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pre-Exposure Prophylaxis Production Mode & Process Analysis
7.4 Pre-Exposure Prophylaxis Sales and Marketing
7.4.1 Pre-Exposure Prophylaxis Sales Channels
7.4.2 Pre-Exposure Prophylaxis Distributors
7.5 Pre-Exposure Prophylaxis Customer Analysis
8 Pre-Exposure Prophylaxis Market Dynamics
8.1 Pre-Exposure Prophylaxis Industry Trends
8.2 Pre-Exposure Prophylaxis Market Drivers
8.3 Pre-Exposure Prophylaxis Market Challenges
8.4 Pre-Exposure Prophylaxis Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Gilead Sciences
Teva Pharmaceuticals
Strides Pharma Science
Lupin Ltd
List of Tables
 Table 1. Global Pre-Exposure Prophylaxis Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pre-Exposure Prophylaxis Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pre-Exposure Prophylaxis Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pre-Exposure Prophylaxis Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pre-Exposure Prophylaxis Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pre-Exposure Prophylaxis Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pre-Exposure Prophylaxis Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pre-Exposure Prophylaxis Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pre-Exposure Prophylaxis, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pre-Exposure Prophylaxis, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pre-Exposure Prophylaxis, Product Type & Application
 Table 12. Global Key Manufacturers of Pre-Exposure Prophylaxis, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pre-Exposure Prophylaxis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Exposure Prophylaxis as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pre-Exposure Prophylaxis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pre-Exposure Prophylaxis Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pre-Exposure Prophylaxis Sales Market Share by Region (2020-2025)
 Table 19. Global Pre-Exposure Prophylaxis Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pre-Exposure Prophylaxis Sales Market Share by Region (2026-2031)
 Table 21. Global Pre-Exposure Prophylaxis Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2020-2025)
 Table 23. Global Pre-Exposure Prophylaxis Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2026-2031)
 Table 25. North America Pre-Exposure Prophylaxis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pre-Exposure Prophylaxis Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pre-Exposure Prophylaxis Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pre-Exposure Prophylaxis Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pre-Exposure Prophylaxis Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pre-Exposure Prophylaxis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pre-Exposure Prophylaxis Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pre-Exposure Prophylaxis Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pre-Exposure Prophylaxis Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pre-Exposure Prophylaxis Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pre-Exposure Prophylaxis Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pre-Exposure Prophylaxis Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pre-Exposure Prophylaxis Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pre-Exposure Prophylaxis Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pre-Exposure Prophylaxis Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pre-Exposure Prophylaxis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pre-Exposure Prophylaxis Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pre-Exposure Prophylaxis Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pre-Exposure Prophylaxis Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pre-Exposure Prophylaxis Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pre-Exposure Prophylaxis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pre-Exposure Prophylaxis Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pre-Exposure Prophylaxis Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pre-Exposure Prophylaxis Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pre-Exposure Prophylaxis Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pre-Exposure Prophylaxis Sales (K Units) by Type (2020-2025)
 Table 51. Global Pre-Exposure Prophylaxis Sales (K Units) by Type (2026-2031)
 Table 52. Global Pre-Exposure Prophylaxis Sales Market Share by Type (2020-2025)
 Table 53. Global Pre-Exposure Prophylaxis Sales Market Share by Type (2026-2031)
 Table 54. Global Pre-Exposure Prophylaxis Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pre-Exposure Prophylaxis Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2020-2025)
 Table 57. Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2026-2031)
 Table 58. Global Pre-Exposure Prophylaxis Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Pre-Exposure Prophylaxis Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Pre-Exposure Prophylaxis Sales (K Units) by Application (2020-2025)
 Table 61. Global Pre-Exposure Prophylaxis Sales (K Units) by Application (2026-2031)
 Table 62. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2020-2025)
 Table 63. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2026-2031)
 Table 64. Global Pre-Exposure Prophylaxis Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pre-Exposure Prophylaxis Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2020-2025)
 Table 67. Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2026-2031)
 Table 68. Global Pre-Exposure Prophylaxis Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Pre-Exposure Prophylaxis Price (US$/Unit) by Application (2026-2031)
 Table 70. Gilead Sciences Company Information
 Table 71. Gilead Sciences Description and Business Overview
 Table 72. Gilead Sciences Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Gilead Sciences Pre-Exposure Prophylaxis Product
 Table 74. Gilead Sciences Recent Developments/Updates
 Table 75. Teva Pharmaceuticals Company Information
 Table 76. Teva Pharmaceuticals Description and Business Overview
 Table 77. Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Teva Pharmaceuticals Pre-Exposure Prophylaxis Product
 Table 79. Teva Pharmaceuticals Recent Developments/Updates
 Table 80. Strides Pharma Science Company Information
 Table 81. Strides Pharma Science Description and Business Overview
 Table 82. Strides Pharma Science Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Strides Pharma Science Pre-Exposure Prophylaxis Product
 Table 84. Strides Pharma Science Recent Developments/Updates
 Table 85. Lupin Company Information
 Table 86. Lupin Description and Business Overview
 Table 87. Lupin Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Lupin Pre-Exposure Prophylaxis Product
 Table 89. Lupin Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Pre-Exposure Prophylaxis Distributors List
 Table 93. Pre-Exposure Prophylaxis Customers List
 Table 94. Pre-Exposure Prophylaxis Market Trends
 Table 95. Pre-Exposure Prophylaxis Market Drivers
 Table 96. Pre-Exposure Prophylaxis Market Challenges
 Table 97. Pre-Exposure Prophylaxis Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pre-Exposure Prophylaxis
 Figure 2. Global Pre-Exposure Prophylaxis Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pre-Exposure Prophylaxis Market Share by Type: 2024 & 2031
 Figure 4. Truvada Product Picture
 Figure 5. Discovy Product Picture
 Figure 6. Global Pre-Exposure Prophylaxis Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pre-Exposure Prophylaxis Market Share by Application: 2024 & 2031
 Figure 8. Adult
 Figure 9. Adolescent
 Figure 10. Global Pre-Exposure Prophylaxis Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Pre-Exposure Prophylaxis Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Pre-Exposure Prophylaxis Sales (2020-2031) & (K Units)
 Figure 13. Global Pre-Exposure Prophylaxis Average Price (US$/Unit) & (2020-2031)
 Figure 14. Pre-Exposure Prophylaxis Report Years Considered
 Figure 15. Pre-Exposure Prophylaxis Sales Share by Manufacturers in 2024
 Figure 16. Global Pre-Exposure Prophylaxis Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Pre-Exposure Prophylaxis Players: Market Share by Revenue in Pre-Exposure Prophylaxis in 2024
 Figure 18. Pre-Exposure Prophylaxis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Pre-Exposure Prophylaxis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Pre-Exposure Prophylaxis Sales Market Share by Country (2020-2031)
 Figure 21. North America Pre-Exposure Prophylaxis Revenue Market Share by Country (2020-2031)
 Figure 22. United States Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Pre-Exposure Prophylaxis Sales Market Share by Country (2020-2031)
 Figure 25. Europe Pre-Exposure Prophylaxis Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Pre-Exposure Prophylaxis Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Pre-Exposure Prophylaxis Revenue Market Share by Region (2020-2031)
 Figure 33. China Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Pre-Exposure Prophylaxis Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Pre-Exposure Prophylaxis Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Pre-Exposure Prophylaxis Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Pre-Exposure Prophylaxis Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Pre-Exposure Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Pre-Exposure Prophylaxis by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Pre-Exposure Prophylaxis by Type (2020-2031)
 Figure 54. Global Pre-Exposure Prophylaxis Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Pre-Exposure Prophylaxis by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Pre-Exposure Prophylaxis by Application (2020-2031)
 Figure 57. Global Pre-Exposure Prophylaxis Price (US$/Unit) by Application (2020-2031)
 Figure 58. Pre-Exposure Prophylaxis Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Injectable HIV Medication Market Research Report 2024
Global Injectable HIV Treatment Market Research Report 2024
Global Preoperative Skin Preparation Market Research Report 2024
Global Prophylaxis Angles And Cups Market Research Report 2024
Stavudine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prophylactic HIV Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global HIV Therapy Market Research Report 2025
Global Long acting Anti HIV Drugs Market Research Report 2024
Global Drug for Organ Rejection Prophylaxis Market Research Report 2025
Global Tenofovir Fumarate Market Research Report 2024
Global Preoperative Skin Preparation Products Market Research Report 2024
Global Aprepitant Preparations Market Research Report 2024
Global Drugs for PrEP Market Research Report 2024
Global Pre Exposure Prophylaxis PrEP Market Research Report 2024
Global Parenteral PrEP Market Research Report 2024
Global Long acting PrEP Market Research Report 2024
Global Clinical Sample Prep System Market Research Report 2024
Global Enfuvirtide for Injection Market Research Report 2024
Global HIV Diagnosis Market Research Report 2024
Global Oral Preservative Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions